Research Triangle manufacturing expansion
Novartis, Durham, North Carolina
Research Triangle manufacturing expansion in Durham, North Carolina is Novartis’ plant for advanced biologics, gene therapy, fill/finish and packaging, small molecule medicines. Status: under construction as of December 11, 2025 (groundbreaking). Novartis announced $771 million and 700 jobs. Primary source: governor.nc.gov, checked November 12, 2026.
- Status
- Under construction
- Announced investment
- $771 million
- Announced jobs
- 700
- Industry
- Pharmaceuticals
- Sheet
- NC-30
- Revised
- November 12, 2026
Status timeline
- Announcedgovernor.nc.gov
- Groundbreakinggovernor.nc.gov
Filled dots are confirmed by a company, state, SEC or federal source. Dashed dots come from news reports only. Investment and job figures are as announced, not achieved.
Plant facts
| Company | Novartis |
|---|---|
| Plant | Research Triangle manufacturing expansion |
| Location | Durham, North Carolina |
| Industry | Pharmaceuticals |
| Product | Advanced biologics, gene therapy, fill/finish and packaging, small molecule medicines |
| Announced investment | $771 millionThree sites in City of Durham and Town of Morrisville (Durham and Wake counties) |
| Announced jobs | 700 |
| Last checked | November 12, 2026 |
Sources
- Novartis to expand U.S. manufacturing in Durham and Wake counties, 700 jobs, $771M (state release, governor.nc.gov, checked November 12, 2026)
- Governor Stein celebrates Novartis groundbreaking and expansion in Research Triangle (state release, governor.nc.gov, checked November 12, 2026)
Something changed? Send a correction with a link and we'll recheck it.